Format

Send to

Choose Destination
Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1201-1205. doi: 10.1080/00365521.2018.1506820. Epub 2018 Oct 24.

Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction.

Author information

1
a Division of Gastroenterology, Department of Internal Medicine , Catholic Kwandong, University International St. Mary's Hospital , Incheon , Korea.
2
b Division of Gastroenterology, Department of Internal Medicine , Gil Medical Center, Gachon University College of Medicine , Incheon , Korea.
3
c Department of Rehabilitation Medicine , Gil Medical Center, Gachon University College of Medicine , Incheon , Korea.

Abstract

BACKGROUND:

Dysphagia associated with neurologic disorders is a problem worldwide. However, few studies have assessed the efficacy of endoscopic botulinum toxin injections into the cricopharyngeal muscle using a pharyngoscope.

METHODS:

Fourteen patients who received an endoscopic botulinum toxin injection due to cricopharyngeal muscle dysfunction and a neurological disorder from 2006 to 2017 were retrospectively reviewed at a single tertiary medical center. The toxin was injected at a 100 international unit (IU) total dose under direct endoscopic vision. The success of the procedure was evaluated comprehensively using the following: clinical resolution of the previous symptoms, functional oral intake scale (FOIS) for the clinical evaluation of swallowing, and videofluoroscopic swallowing study (VFSS) to check decreased retention of barium at the pyriform sinus and the epiglottic vallecula.

RESULTS:

The study included 12 males and 2 females (mean age, 58 years old; range, 37-82 years). Three patients (21.4%) were confirmed clinically and eleven were confirmed by VFSS. Eleven patients (78.6%) were managed successfully with the injection. Three patients (21.4%) did not improve despite the injection.

CONCLUSION:

An endoscopic botulinum toxin injection may be a good treatment option for patients with dysphagia and cricopharyngeal dysfunction due to a neurological disorder. Large, prospective, long-term follow-up studies are needed in the future.

KEYWORDS:

Cricopharyngeal muscle; botulinum; dysphagia; endoscopic; endoscopic botulinum neurotoxin injection

PMID:
30353754
DOI:
10.1080/00365521.2018.1506820
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center